Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19

We validate a deep learning model predicting comorbidities from frontal chest radiographs (CXRs) in patients with coronavirus disease 2019 (COVID-19) and compare the model’s performance with hierarchical condition category (HCC) and mortality outcomes in COVID-19. The model was trained and tested on...

Full description

Bibliographic Details
Main Authors: Ayis Pyrros, Jorge Rodriguez Fernandez, Stephen M. Borstelmann, Adam Flanders, Daniel Wenzke, Eric Hart, Jeanne M. Horowitz, Paul Nikolaidis, Melinda Willis, Andrew Chen, Patrick Cole, Nasir Siddiqui, Momin Muzaffar, Nadir Muzaffar, Jennifer McVean, Martha Menchaca, Aggelos K. Katsaggelos, Sanmi Koyejo, William Galanter
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2022-08-01
Series:PLOS Digital Health
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931278/?tool=EBI
_version_ 1797726945237008384
author Ayis Pyrros
Jorge Rodriguez Fernandez
Stephen M. Borstelmann
Adam Flanders
Daniel Wenzke
Eric Hart
Jeanne M. Horowitz
Paul Nikolaidis
Melinda Willis
Andrew Chen
Patrick Cole
Nasir Siddiqui
Momin Muzaffar
Nadir Muzaffar
Jennifer McVean
Martha Menchaca
Aggelos K. Katsaggelos
Sanmi Koyejo
William Galanter
author_facet Ayis Pyrros
Jorge Rodriguez Fernandez
Stephen M. Borstelmann
Adam Flanders
Daniel Wenzke
Eric Hart
Jeanne M. Horowitz
Paul Nikolaidis
Melinda Willis
Andrew Chen
Patrick Cole
Nasir Siddiqui
Momin Muzaffar
Nadir Muzaffar
Jennifer McVean
Martha Menchaca
Aggelos K. Katsaggelos
Sanmi Koyejo
William Galanter
author_sort Ayis Pyrros
collection DOAJ
description We validate a deep learning model predicting comorbidities from frontal chest radiographs (CXRs) in patients with coronavirus disease 2019 (COVID-19) and compare the model’s performance with hierarchical condition category (HCC) and mortality outcomes in COVID-19. The model was trained and tested on 14,121 ambulatory frontal CXRs from 2010 to 2019 at a single institution, modeling select comorbidities using the value-based Medicare Advantage HCC Risk Adjustment Model. Sex, age, HCC codes, and risk adjustment factor (RAF) score were used. The model was validated on frontal CXRs from 413 ambulatory patients with COVID-19 (internal cohort) and on initial frontal CXRs from 487 COVID-19 hospitalized patients (external cohort). The discriminatory ability of the model was assessed using receiver operating characteristic (ROC) curves compared to the HCC data from electronic health records, and predicted age and RAF score were compared using correlation coefficient and absolute mean error. The model predictions were used as covariables in logistic regression models to evaluate the prediction of mortality in the external cohort. Predicted comorbidities from frontal CXRs, including diabetes with chronic complications, obesity, congestive heart failure, arrhythmias, vascular disease, and chronic obstructive pulmonary disease, had a total area under ROC curve (AUC) of 0.85 (95% CI: 0.85–0.86). The ROC AUC of predicted mortality for the model was 0.84 (95% CI,0.79–0.88) for the combined cohorts. This model using only frontal CXRs predicted select comorbidities and RAF score in both internal ambulatory and external hospitalized COVID-19 cohorts and was discriminatory of mortality, supporting its potential use in clinical decision making. Author summary Artificial Intelligence algorithms in Radiology can be used not only on standard imaging data like chest radiographs to predict diagnoses but can also incorporate other data. We wanted to find out if we could combine administrative and demographic data with chest radiographs to predict common comorbidities and mortality. Our deep learning algorithm was able to predict diabetes with chronic complications, obesity, congestive heart failure, arrythmias, vascular disease, and chronic obstructive pulmonary disease. The deep learning algorithm was also able to predict an administrative metric (RAF score) used in value-based Medicare Advantage plans. We used these predictions as biomarkers to predict mortality with a second statistical model using logistic regression in COVID-19 patients both in and out of the hospital. The degree of discrimination both the deep learning algorithm and statistical model provide would be considered ‘good’ by most, and certainly much better than chance alone. It was measured at 0.85 (95% CI: 0.85–0.86) by the area under the ROC curve method for the artificial intelligence algorithm, and 0.84 (95% CI:0.79–0.88) by the same method for the statistical mortality prediction model.
first_indexed 2024-03-12T10:52:44Z
format Article
id doaj.art-a4e4f2efe4f2446d9fa2eee8e7a81ab4
institution Directory Open Access Journal
issn 2767-3170
language English
last_indexed 2024-03-12T10:52:44Z
publishDate 2022-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLOS Digital Health
spelling doaj.art-a4e4f2efe4f2446d9fa2eee8e7a81ab42023-09-02T06:49:14ZengPublic Library of Science (PLoS)PLOS Digital Health2767-31702022-08-0118Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19Ayis PyrrosJorge Rodriguez FernandezStephen M. BorstelmannAdam FlandersDaniel WenzkeEric HartJeanne M. HorowitzPaul NikolaidisMelinda WillisAndrew ChenPatrick ColeNasir SiddiquiMomin MuzaffarNadir MuzaffarJennifer McVeanMartha MenchacaAggelos K. KatsaggelosSanmi KoyejoWilliam GalanterWe validate a deep learning model predicting comorbidities from frontal chest radiographs (CXRs) in patients with coronavirus disease 2019 (COVID-19) and compare the model’s performance with hierarchical condition category (HCC) and mortality outcomes in COVID-19. The model was trained and tested on 14,121 ambulatory frontal CXRs from 2010 to 2019 at a single institution, modeling select comorbidities using the value-based Medicare Advantage HCC Risk Adjustment Model. Sex, age, HCC codes, and risk adjustment factor (RAF) score were used. The model was validated on frontal CXRs from 413 ambulatory patients with COVID-19 (internal cohort) and on initial frontal CXRs from 487 COVID-19 hospitalized patients (external cohort). The discriminatory ability of the model was assessed using receiver operating characteristic (ROC) curves compared to the HCC data from electronic health records, and predicted age and RAF score were compared using correlation coefficient and absolute mean error. The model predictions were used as covariables in logistic regression models to evaluate the prediction of mortality in the external cohort. Predicted comorbidities from frontal CXRs, including diabetes with chronic complications, obesity, congestive heart failure, arrhythmias, vascular disease, and chronic obstructive pulmonary disease, had a total area under ROC curve (AUC) of 0.85 (95% CI: 0.85–0.86). The ROC AUC of predicted mortality for the model was 0.84 (95% CI,0.79–0.88) for the combined cohorts. This model using only frontal CXRs predicted select comorbidities and RAF score in both internal ambulatory and external hospitalized COVID-19 cohorts and was discriminatory of mortality, supporting its potential use in clinical decision making. Author summary Artificial Intelligence algorithms in Radiology can be used not only on standard imaging data like chest radiographs to predict diagnoses but can also incorporate other data. We wanted to find out if we could combine administrative and demographic data with chest radiographs to predict common comorbidities and mortality. Our deep learning algorithm was able to predict diabetes with chronic complications, obesity, congestive heart failure, arrythmias, vascular disease, and chronic obstructive pulmonary disease. The deep learning algorithm was also able to predict an administrative metric (RAF score) used in value-based Medicare Advantage plans. We used these predictions as biomarkers to predict mortality with a second statistical model using logistic regression in COVID-19 patients both in and out of the hospital. The degree of discrimination both the deep learning algorithm and statistical model provide would be considered ‘good’ by most, and certainly much better than chance alone. It was measured at 0.85 (95% CI: 0.85–0.86) by the area under the ROC curve method for the artificial intelligence algorithm, and 0.84 (95% CI:0.79–0.88) by the same method for the statistical mortality prediction model.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931278/?tool=EBI
spellingShingle Ayis Pyrros
Jorge Rodriguez Fernandez
Stephen M. Borstelmann
Adam Flanders
Daniel Wenzke
Eric Hart
Jeanne M. Horowitz
Paul Nikolaidis
Melinda Willis
Andrew Chen
Patrick Cole
Nasir Siddiqui
Momin Muzaffar
Nadir Muzaffar
Jennifer McVean
Martha Menchaca
Aggelos K. Katsaggelos
Sanmi Koyejo
William Galanter
Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19
PLOS Digital Health
title Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19
title_full Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19
title_fullStr Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19
title_full_unstemmed Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19
title_short Validation of a deep learning, value-based care model to predict mortality and comorbidities from chest radiographs in COVID-19
title_sort validation of a deep learning value based care model to predict mortality and comorbidities from chest radiographs in covid 19
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931278/?tool=EBI
work_keys_str_mv AT ayispyrros validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT jorgerodriguezfernandez validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT stephenmborstelmann validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT adamflanders validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT danielwenzke validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT erichart validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT jeannemhorowitz validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT paulnikolaidis validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT melindawillis validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT andrewchen validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT patrickcole validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT nasirsiddiqui validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT mominmuzaffar validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT nadirmuzaffar validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT jennifermcvean validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT marthamenchaca validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT aggeloskkatsaggelos validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT sanmikoyejo validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19
AT williamgalanter validationofadeeplearningvaluebasedcaremodeltopredictmortalityandcomorbiditiesfromchestradiographsincovid19